Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: A systematic review and network meta-analysis.

Frontiers in neurology(2023)

引用 0|浏览13
暂无评分
摘要
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=283424, identifier: CRD42021283424.
更多
查看译文
关键词
FDA-approved monoclonal antibodies (mAbs),network-meta analysis,neuromyelitis optica spectrum disorder (NMOSD),off-label monoclonal antibodies,relapse
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要